These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 22952029

  • 1. Chemotherapy and radiotherapy combination extends survival for patients with oligodendroglial tumors.
    Printz C.
    Cancer; 2012 Sep 15; 118(18):4368. PubMed ID: 22952029
    [No Abstract] [Full Text] [Related]

  • 2. Anaplastic oligodendroglial tumors: a tale of two trials.
    Gilbert MR, Lang FF.
    J Clin Oncol; 2006 Jun 20; 24(18):2689-90. PubMed ID: 16782906
    [No Abstract] [Full Text] [Related]

  • 3. Anaplastic oligodendroglioma and oligoastrocytoma.
    van den Bent MJ.
    Neurol Clin; 2007 Nov 20; 25(4):1089-109, ix-x. PubMed ID: 17964027
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.
    Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687
    [Abstract] [Full Text] [Related]

  • 5. How to use molecular markers when caring for a patient with brain cancer: 1P/19Q as a predictive and prognostic marker in the neuro-oncology clinic.
    van den Bent MJ.
    Am Soc Clin Oncol Educ Book; 2013 Feb 15; ():114-6. PubMed ID: 23714473
    [Abstract] [Full Text] [Related]

  • 6. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.
    Cairncross JG, Wang M, Jenkins RB, Shaw EG, Giannini C, Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ, Huse JT, Mehta MP, Curran WJ.
    J Clin Oncol; 2014 Mar 10; 32(8):783-90. PubMed ID: 24516018
    [Abstract] [Full Text] [Related]

  • 7. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
    Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsay DA, Nimer SD, DeAngelis LM, Cairncross JG.
    Neuro Oncol; 2006 Apr 10; 8(2):183-8. PubMed ID: 16524945
    [Abstract] [Full Text] [Related]

  • 8. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T, Nettekoven W, Kraus JA, Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
    J Neurol; 2002 Aug 10; 249(8):1055-7. PubMed ID: 12195453
    [Abstract] [Full Text] [Related]

  • 9. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
    Mokhtari K, Ducray F, Kros JM, Gorlia T, Idbaih A, Taphoorn M, Wesseling P, Hoang-Xuan K, Van den Bent M, Sanson M.
    Cancer; 2011 Jul 01; 117(13):3014-26. PubMed ID: 21246521
    [Abstract] [Full Text] [Related]

  • 10. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
    Macdonald DR, Gaspar LE, Cairncross JG.
    Ann Neurol; 1990 May 01; 27(5):573-4. PubMed ID: 2360797
    [Abstract] [Full Text] [Related]

  • 11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R, Nobile M, Rudà R, Borgognone M, Costanza A, Laguzzi E, Mutani R.
    Cancer; 2004 Feb 15; 100(4):807-13. PubMed ID: 14770438
    [Abstract] [Full Text] [Related]

  • 12. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M.
    Strahlenther Onkol; 2003 Apr 15; 179(4):219-32. PubMed ID: 12707711
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy of oligodendroglial tumours: current developments.
    van den Bent MJ.
    Forum (Genova); 2000 Apr 15; 10(2):108-18. PubMed ID: 10875973
    [Abstract] [Full Text] [Related]

  • 14. [The molecular genetics of oligodendroglioma].
    Teng LH, Gui QP, Xuan Q, Lu DH.
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct 15; 33(5):471-3. PubMed ID: 15498225
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy for oligodendroglioma. Progress report.
    Cairncross JG, Macdonald DR.
    Arch Neurol; 1991 Feb 15; 48(2):225-7. PubMed ID: 1993014
    [No Abstract] [Full Text] [Related]

  • 16. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM.
    Cancer; 2003 Mar 01; 97(5):1276-84. PubMed ID: 12599236
    [Abstract] [Full Text] [Related]

  • 17. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M, Ushio Y.
    Gan To Kagaku Ryoho; 2002 May 01; 29(5):669-76. PubMed ID: 12040669
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA.
    Cancer Gene Ther; 2006 Sep 01; 13(9):886-95. PubMed ID: 16645619
    [Abstract] [Full Text] [Related]

  • 19. Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
    Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, Cairncross JG, Kros JM, Ashby LS, Taphoorn MJB, Souhami L, Dinjens WNM, Laack NN, Kouwenhoven MCM, Fink KL, French PJ, Macdonald DR, Lacombe D, Won M, Gorlia T, Mehta MP, van den Bent MJ.
    J Clin Oncol; 2022 Aug 10; 40(23):2539-2545. PubMed ID: 35731991
    [Abstract] [Full Text] [Related]

  • 20. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH, Hong YK, Yoon SC, Kim BS, Lee YS, Lee TK, Lee KS, Jeun SS, Kim MC, Park CK.
    Oncol Rep; 2007 Jun 10; 17(6):1359-64. PubMed ID: 17487391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.